Three abstracts presented at the 2022 EULAR Congress shed new light on risk of a wide...

The use of a novel agent, sacituzumab govitecan, an antibody-drug conjugate, resulted...

Malignant melanoma, the most serious type of skin cancer, is the fifth most commonly...

Ibrutinib combined with bendamustine-rituximab improved PFS by 50 per cent for older patients with newly-diagnosed mantle...

The use of panitumumab plus mFOLFOX6 significantly improved OS in patients with RAS wild-type...

The use of autologous stem cell transplant (ASCT) early in the course of treatment showed a...

The addition of nimotuzumab to gemcitabine increases OS in patients with KRAS wild-type advanced...

New research has provided important insight into what drives metastases in prostate cancer...

Migraine is a complex neurological disorder. Although not life-threatening, migraine has...

Since the beginning of 2022, the Migraine Association of Ireland (MAI) has seen an increase in...

Attendees at UCD’s Charles Institute Seminar Series heard a presentation by Prof Dennis McGonagle...

Attendees at UCD’s Charles Institute Seminar Series heard a presentation by skin research specialist...